Asociación de la expresión de los receptores de TNF-a (TNFR1 y TNFR2) al estadio de cáncer de mama
Contenido principal del artículo
Resumen
El cáncer es un crecimiento celular no controlado por los ciclos de regulación normales que llevan a morbi-mortalidad del individuo. A nivel de salud pública mundial es un fenómeno demográfico creciente. En particular el cáncer mamario es la primera causa de mortalidad en mujeres. Este padecimiento se estadifica mediante la clasificación TNM o el grado histológico Bloom-Richardson. Estudios previos en tejidos neoplásicos mamarios han correlacionado la expresión del receptor 1 del TNF-a (TNFR1), con el fenómeno de apoptosis y la expresión del receptor 2 del TNF-a (TNFR2) con el fenómeno de hiperproliferación.
Detalles del artículo
Sección
Cómo citar
Referencias
Wan-Wan L, Karin M. A cytocine-mediated link between innate inmunity, inflamation and cancer. Rev Series 2007; 117(5): 1175-83.
Hickey M, Peate M, Saunders CM, Frielander M. Breast cancer in Young women and its impact on reproductive function. Hum Reprod Updat 2009; 15(3): 323-39.
INEGI, Manual Mujeres y Hombres en México 2009., decimotercera Edición. México. http:www.inegi.gob.mx (Última visita: Abril de 2010).
Arthritis and Rheumatism 2009; 60: 3180-9.
Archivo Clínico de la Clínica de Especialidades de la Mujer (última visita Abril de 2010).
Elías S, Contreras A, Llanque C. Cáncer o carcinoma de mama. Rev Paceña Med Fam 2008; 5(7): 14-23.
Hongjuan Z, Langerod A, Youngran J, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, et al. Different gene expression patterns in invasive lobular and ductal carcinomas of the breast. Molecular Biology of the Cell 2004; 5: 1-46.
Torres GFJ, Torres OFJ. Estudio comparativo de diferentes métodos de valoración de la angiogénesis en el carcinoma ductal infiltrante de mama. Rev Esp de Patol 2006; 19(2): 1-9.
Zhang Q, Fan Hanil, Shen J, Hoffman RM, Xing HS. Human breast cancercell lines co-express neuronal, epithelial and melanocytic differentiation markers in vivo and in vitro. Plos One 2010; 5(3): 1-7.
Caldon E, Daly R, Sutherland RL, Musgrove EA. Cell cycle control in breast cancer cells. J Cell Biochem 2006; 97: 261-74.
King BL, Love SM, Rochman S, Kim JA. The Fourth International Symposium on the intraductal approach to breast cancer. Santa Barbara, California. Breast Cancer Research 2005; 7(5): 198-204.
Swann JB, Smyth M. Immune surveillance of tumors. J Clin Inves 2007; 117(5): 1137-46.
American Joint Comitteé on Cancer (AJCC). Cancer Staging Manual. 7th. Ed. 2002; 2: 43-9.
Haybittle JL, Blamey RW, Elston CW, Johnson J, Doyle PJ, Campbell FC, Nicholson RI, Griffiths K. A prognostic index in primary breast cancer. Br J Cancer 1982; 45: 361-7.
Sica A, Bronte V. Altered macrophage differentiation and immune dysfunction in tumor development. Rev Series 2007; 117(5): 1155-66.
Waterston A, Bower M. TNF and cancer: good or bad. Cancer Therapy 2004; 2: 131-48.
Abbasi YA, Rehn M, Ekman N, Alitalo K, Vuori K. Pl 130Cas Couples the tyrosine kinase Bmx/Etk with regulation of the actin cytoskeleton and cell migration. J Biol Chem 1976; 278: 3536-43.
Grivennikov IS, Tumanov AV, Ryffel B, Kuprash DV, Shakhov AN, Murakami T, Drutskaya LN, et al. Distinct and nonredundant in vivo functions of TNF produced by T cells and Macrophages/ neutrophils: protective and deleterious effects. Immunity 2005; 22: 93- 104.
Balkwill F. Tumor necrosis factor and cancer. Nat Rev Can 2009; 9: 361-71.
Sheti G, Sung B, Aggarwal BB. TNF: A master switch for inflammation to cancer. Frontieres in Bioscience 2008; 1(13): 5094-107.
Berek JS, Adashi EY, Hillard P. Enfermedad mamaria e influencias hormonales. Ginecología de Novak 1996; 12a. Ed. Mc-Graw Hill Interamericana; 18: 525-39.
Wu Y, Zhou BP. TNF-a/NFkB/Snail signaling pathway in cancer cell. migration and invasion. Br J Can 2010; 102: 639-44.
Xiuhua G, Zafar N. Role of steroid receptor coactivators and corepressors of progesterone receptors in breast cancer. Breast Cancer Research 2002; 4: 182-6.
Moshin S, Weiss H, Havighurst T, Clark G, Berardo M, Roanh L, Qian Z, et al. Progesterone receptor by inmunohistochemistry and clinical outcome in breast cancer: a validatioin study. Modern Pathology 2004; 17: 1545-54.
Mammary Gland Development Database. Expression of receptors and signal transduction molecules during mammary gland development. Fuente: dh5@holyrrod.ed.ac.uk. Fecha de última consulta: 28-Enero-11.
Varela LM, Ip MM. Tumor necrosis factor-a: a multifunctional regulator of mammary gland development. Endocrinology 1996: 137: 4915-24.
Santanu D, Sanober A, Ayse C, Mehmet B, Takashi S, Hironobu S, Serdar B. Estrogenreceptors expression of Tumor Necrosis Factor receptors in breast adipose fibroblast. J Clin Endocrinol Metabol 2004; 89(8): 4018-24.
Neeraja D, Peng W, Carson D. Cytocine and progesterone receptor interplay in the regulation of MUC1 gene expression. Molecular Endocrinology 2009; 24(12): 2253-66.
Mizuho N, Noboru M, Naoko I, Toshikatsu M, Miyamoto H. Changes in the expression of Tumor Necrosis Factor a, TNFR and TNFR-associated Factor in granulose cells during atresia in pig ovaries. Biol Reprod 2003; 68: 530-35.
Bissel M, Hillarrd J. Inflamlde PV. Inflamation and breast cancer. Metalloproteinases as common effector. Breast Cancer Research 2008;
(2): 1-17.
Rivas MA, Carnevale RP, Proietti CJ, Beguelin W, Charreau EH, Frahm I, Sapia S, et al. TNF alpha acting on TNFR1 promotes breast cancer growth via p42/p44 MAPK, JNK Akt and NFkB dependent pathways. Exp Cell Res 2008; 314(3): 509-29.
Grech A, gardman S, Chan T, Quinn R, González R, Basten A and Brinks R. Tumor necrosis factor receptor 2 (TRAF2) signaling is negatively regulated by a novel carboxilterminal TNFR associated factor 2 binding site. J Biol Chem 2005; 280(36): 31572-81.
Masmudur MR, Lucas A, McFadden G. Viral TNF inhibitors as potential therapeutics. Fuente: Madame Curie BiosciencieDatabase. Austin Tx. Fecha de última consulta: 28-Enero-2011.
Gelbish G, Davidson AL, Kopel S, Schreibman B, Degenshein GA, Burton L, Cunnigham J. Relationship of estrogen and progesterone receptors to prognosis in breast cancer. Ann Surg 1998; 5: 75-81.
Calaf G, Ramirez G, Jordan C. Acción de estrógenos y antiestrógenos en el cáncer mamario. Algunos aspectos básicos. INC. 31(3):
-91.
Fisher Scientific Catalog. Anti-progestin Glcb Ab-2, polyclonal.Thermo Scientific, Pierce. Fecha de últimaconsulta: 28-Ene-2011.